Active

RevaTis

Switched

BE0541682642

Rechtspersoon Public limited company 1 establishment

Aye, Rue de la Science 8, 6900 Marche-en-Famenne Groothandel in farmaceutische en medische artikelen

Active for

12 year, 10 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ 136,602

▼ 77% vs 2024

Profit

Caution

€ -620,715

▼ 137% vs 2024

Debts

Low

€ 1.6 million

▲ 34% vs 2024

RevaTis from Marche-en-Famenne, company number BE0541682642, closed financial year 2025 with a result of € -620,715 after tax. For that financial year RevaTis recorded a gross margin of € 136,602 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € -262,021 to € -620,715. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What happened at RevaTis?

What happened at RevaTis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 620,715. Source: NBB ↗
  • Start of the company according to the CBE. KBO
  • New establishment in Marche-en-Famenne. KBO

In short

From € 58,529 profit in 2021 to € 620,715 loss in 2025.

Paid € 2,401 in corporate taxes since 2021.

Best year ever: 2021, with € 58,529 profit.

On average € 106,500 of value added per employee in 2024.

A new publication or filing at RevaTis? We notify you, reason included.

Follow RevaTis

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jean-Paul LACOMBLE
Jean-Luc MARTIN
Jacques KUYPERS
+8

Behind RevaTis are NOSHAQ PARTNERS, Jean-Paul LACOMBLE, Jean-Luc MARTIN, Jacques KUYPERS, SALAMANDER U. and Philippe NEVEN. The same people are also behind CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM and VITAVERDE.BIO.

See the full network in the app

Directors

According to the 2025 annual accounts

NOSHAQ PARTNERS

Director · represented by Frédéric SCHYNTS

Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more

Jean-Paul LACOMBLE

Director

Jean-Luc MARTIN

Director

Jacques KUYPERS

Director

SALAMANDER U.

Director · represented by Jean-Claude DEDRY

Philippe NEVEN

Director

Jean-Loup BLONDEAU

Director

Didier SERTEYN

Director

Jean-Claude HAVAUX

Director

Alexandre DALLEMAGNE

Director

Joseph MARTIAL

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Aye, Rue de la Science 8

6900 Marche-en-Famenne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0541.682.642
VAT number
BE 0541.682.642
Registered office
Aye, Rue de la Science 8, 6900 Marche-en-Famenne
Names & denominations
RevaTis
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
6 November 2013
Peppol
Active · Active since 20 Nov 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Vervaardiging van geneesmiddelen

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of RevaTis?
The enterprise number of RevaTis is BE0541682642.
What is the address of RevaTis?
The registered office of RevaTis is located at Aye, Rue de la Science 8, 6900 Marche-en-Famenne.
When was RevaTis founded?
RevaTis was founded on 6 November 2013.
What is the main activity of RevaTis?
The main activity of RevaTis is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does RevaTis have a website?
No website is currently known for RevaTis.
How much profit did RevaTis make in 2025?
RevaTis recorded a loss after taxes of € 620,715 in financial year 2025.
What is the revenue of RevaTis?
As a small company, RevaTis is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 136,602.
Where can I find the annual accounts of RevaTis?
RevaTis files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of RevaTis?
According to the 2025 annual accounts, the directors of RevaTis are: NOSHAQ PARTNERS, Jean-Paul LACOMBLE, Jean-Luc MARTIN, Jacques KUYPERS, SALAMANDER U., Philippe NEVEN, Jean-Loup BLONDEAU, Didier SERTEYN.
Who owns RevaTis?
Behind RevaTis are NOSHAQ PARTNERS, Jean-Paul LACOMBLE, Jean-Luc MARTIN, Jacques KUYPERS, SALAMANDER U. and Philippe NEVEN. The same people are also behind CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM and VITAVERDE.BIO.